Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Anthracycline cardiotoxicity: from bench to bedside Gianni L; Herman EH; Lipshultz SE; Minotti G; Sarvazyan N; Sawyer DBJ Clin Oncol 2008[Aug]; 26 (22): 3777-84Anthracyclines remain among the most widely prescribed and effective anticancer agents. Unfortunately, life-threatening cardiotoxicity continues to compromise their usefulness. Despite more than four decades of investigation, the pathogenic mechanisms responsible for anthracycline cardiotoxicity have not been completely elucidated. In addition, new drugs and combination therapies often exacerbate the toxicity. The First International Workshop on Anthracycline Cardiotoxicity, held in fall 2006, in Como, Italy, focused on the state-of-the-art knowledge and discussed the research needed to address the cardiotoxicity of these drugs. Here, we incorporate these discussions into the framework of a broader review of preclinical and clinical issues.|Animals[MESH]|Anthracyclines/*adverse effects[MESH]|Antineoplastic Agents/*adverse effects[MESH]|Biomarkers/metabolism[MESH]|Drug Evaluation, Preclinical/methods[MESH]|Drug Interactions[MESH]|Genetic Predisposition to Disease[MESH]|Heart Diseases/*chemically induced/genetics/metabolism/prevention & control[MESH]|Heart/*drug effects/growth & development[MESH]|Humans[MESH]|Intercellular Signaling Peptides and Proteins/metabolism[MESH]|Models, Animal[MESH]|Myocardium/*metabolism[MESH]|Oxidative Stress/drug effects[MESH]|Patient Selection[MESH]|Practice Guidelines as Topic[MESH]|Risk Assessment[MESH]|Risk Factors[MESH] |
